Altair to Showcase AI-Powered Engineering, Smart Manufacturing, and Connected Aerospace Solutions at Paris Air Show 2025
Live demonstrations will highlight how computational intelligence is shaping the future of…
Deakin University GIFT City Campus announces first successful placement cycle with National Australia Bank’s India Innovation Centre
GANDHINAGAR, India, June 2, 2025 /PRNewswire/ -- Deakin University's GIFT City campus…
Tianfu Rapoil Shines at Hong Kong Hometown Market Carnival
HONG KONG, June 2, 2025 /PRNewswire/ -- This is a report from Xinhuanet:…
Xinhua Silk Road: 21st Shanghai Suzhou Creek Dragon Boat Invitational Tournament concludes with record participation
BEIJING, June 1, 2025 /PRNewswire/ -- The 21st Shanghai Suzhou Creek Dragon Boat…
Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 Development
June 02, 2025 04:00 ET | Source: Aravax MELBOURNE, Australia and OXFORD,…
Press Release Biocartis NV: Biocartis Announces IVDR Class C CDx Certification of the Idylla EGFR Mutation Test
PRESS RELEASE 02/06/2025, 10:00 CEST Biocartis Announces IVDR Class C CDx Certification…
Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition…
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease…
![Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]](https://i0.wp.com/ml-eu.globenewswire.com/media/NjEzMmQ4NzAtZTBkMS00ZDhhLTkyYjgtOGM3YzY1ZWM5M2U5LTEwMTQyODItMjAyNS0wNi0wMi1lbg==/tiny/Sandoz-International-GmbH.png?w=420&resize=420,280&ssl=1 "Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]")
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA…
Lamborghini Super Trofeo Europe: DimitrovGuerin (ProAm) and LevetPutera (Pro) split the wins at Monza
Milestone of 700 drivers since the inaugural edition in 2009 reached at…
